[1]钱博文,王 皓,钟志延,等.精神分裂症患者血清miR-132-3p 和miR-34a-5p 表达水平与认知功能以及诊断的相关性研究[J].现代检验医学杂志,2023,38(01):33-37.[doi:10.3969/j.issn.1671-7414.2023.01.007]
　QIAN Bo-wen,WANG Hao,ZHONG Zhi-yan,et al.Correlation Study of Serum miR-132-3p and miR-34a-5p Expression Levels with Cognitive Function and Diagnosis in Patients with Schizophrenia[J].Journal of Modern Laboratory Medicine,2023,38(01):33-37.[doi:10.3969/j.issn.1671-7414.2023.01.007]
点击复制

精神分裂症患者血清miR-132-3p 和miR-34a-5p 表达水平与认知功能以及诊断的相关性研究()

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年01期
页码:
33-37
栏目:
论著
出版日期:
2023-01-15

文章信息/Info

Title:
Correlation Study of Serum miR-132-3p and miR-34a-5p Expression Levels with Cognitive Function and Diagnosis in Patients with Schizophrenia
文章编号:
1671-7414（2023）01-033-05
作者:
钱博文,王 皓,钟志延,刘春艳
[武汉钢铁(集团) 公司第二职工医院精神心理科，武汉 430080]
Author(s):
QIAN Bo-wen, WANG Hao, ZHONG Zhi-yan, LIU Chun-yan
（Department of Psychiatry，the Second Staff Hospital of Wuhan Iron and Steel (Group) Company, Wuhan 430080，China）
关键词:
miR-132-3p; miR-34a-5p; 精神分裂症; 认知功能
分类号:
R749.3；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.01.007
文献标志码:
A
摘要:
目的 探讨血清微小核糖核酸(micro RNA，miR）-132-3p，miR-34a-5p 表达与精神分裂症患者认知功能的关系，分析其诊断精神分裂症的价值。方法 选择2019 年2 月～ 2021 年10 月武汉钢铁(集团) 公司第二职工医院收治的208 例精神分裂症患者(精神分裂症组）和同期71 例健康体检者(对照组）。检测血清miR-132-3p 和miR-34a-5p表达，Pearson 相关性分析其与精神分裂症患者阳性和阴性症状量表(positive and negative symptom scale，PANSS)、精神分裂症认知功能成套测验(采用MATRICS consensus cognitive battery，MCCB）、Stroop 色词测验评分相关性。受试者工作特征(receiver operating characteristic，ROC）曲线分析miR-132-3p 和miR-34a-5p 诊断精神分裂症的价值。结果 精神分裂症组血清miR-132-3p（3.26±0.84），miR-34a-5p（5.02±1.39）表达均高于对照组(1.05±0.33，1.62±0.5)，差异有统计学意义（t=21.782，20.276，均P ＜ 0.05） ；精神分裂症组MCCB，Stroop 色词测验评分均低于对照组(t=6.651 ～ 16.778，均P ＜ 0.05）。精神分裂症患者血清miR-132-3p，miR-34a-5p 表达与PANSS 总分呈正相关(r=0.502，0.477，均P ＜ 0.05），与连线测验、持续操作测验、语言记忆、Stroop 单词测验评分呈负相关(rmiR-132-3p=-0.501 ～ -0.368，rmiR-34a-5p=-0.483 ～ -0.317，均P ＜ 0.05）。miR-132-3p，miR-34a-5p 诊断精神分裂症的最佳截断值为2.16，3.35，曲线下面积为0.694，0.712，联合miR-132-3p 和miR-34a-5p 诊断精神分裂症的曲线下面积为0.895，大于单独miR-132-3p，miR-34a-5p 诊断(Z=5.747，5.665，均P ＜ 0.05）。结论 miR-132-3p 和miR-34a-5p 表达上调，与精神分裂症症状加重以及认知功能受损有关，miR-132-3p 和miR-34a-5p 联合检测在精神分裂症诊断中具有较高价值。
Abstract:
Objective To investigate the relationship between the expression of serum miR-132-3p and miR-34a-5p and the cognitive function of patients with schizophrenia, and analyze its diagnostic value of schizophrenia. Methods 208 schizophrenic patients (schizophrenia group) admitted to the Second Staff Hospital of Wuhan Iron and Steel (Group) Company from February 2019 to October 2021 were selected, and in addition, 71 healthy patients in the hospital were selected as the control group.The expressions of serum miR-132-3p and miR-34a-5p were detected, and Pearson correlation analysis was conducted for their correlation with positive and negative symptom scale (PANSS), Schizphrenia cognitive function siute test (adopt MCCB) and Stroop color word test scores. Receiver operating characteristic curve (ROC) analyzed the value of miR-132-3p and miR-34a-5p in diagnosis of schizophrenia. Results The levels of miR -132-3p（3.26±0.84） and miR-34A-5p（5.02±1.39） in schizophrenia group were higher than those in control group(3.26±0.84 vs 1.05±0.33, 5.02±1.39 vs 1.62±0.42）,the differences were statistically significant（t=21.782, 20.276，all P < 0.05). MCCB and Stroop test scores were lower than control group (t=6.651 ～ 16.778，all P ＜ 0.05). The expression of miR-132-3p and miR-34a-5p was positively correlated with the total score of PANSS in schizophrenia patients (r=0.502, 0.477, all P ＜ 0.05), and was negatively correlation with the score of connection test, continuous operation test, verbal memory and Stroop word test (rmiR-132-3p= -0.501 ～ -0.368, rmiR-34a-5p= -0.483- ～ 0.317, all P ＜ 0.05). The optimal truncation values of miR-132-3p and miR-34a-5p for the diagnosis of schizophrenia were 2.16 and 3.35, and the area under the curve were 0.694 and 0.712. The area under the curve for the diagnosis of schizophrenia by combining miR-132-3p and miR-34A-5p was 0.895,which were higher than miR-132-3p and miR-34a-5p alone (Z=5.747, 5.665, all P ＜ 0.05). Conclusion The upregulation of miR-132-3p and miR-34a-5p was associated with the aggravation of schizophrenia symptoms and impaired cognitive function, and the combination of miR-132-3p and miR-34A-5p has a high value in the diagnosis of schizophrenia.

参考文献/References:

[1] KESHAVAN M S, COLLIN G, GUIMOND S, et al.Neuroimaging in Schizophrenia[J]. Neuroimaging Clinics of North America, 2020, 30(1): 73-83.
[2] 姚静, 乔云飞, 肖文焕, 等．精神分裂症患者不同疾病状态下认知功能的比较[J]. 国际精神病学杂志,2020, 47(2): 300-303.
YAO Jing, QIAO Yunfei, XIAO Wenhuan, et al.Comparison of cognitive function of schizophrenic patients in the different states of the illness [J]. Journal of International Psychiatry, 2020,47(2):300-303.
[3] RICHETTO J, MEYER U. Epigenetic modifications in schizophrenia and related disorders: molecular scars of environmental exposures and source of phenotypic variability[J]. Biological Psychiatry, 2021, 89(3): 215-226.
[4] HE Kuanjun, GUO Chuang, HE Lin, et al. MiRNAs of peripheral blood as the biomarker of schizophrenia[J].Hereditas, 2018, 155: 9.
[5] VAN DEN BERG M M J, KRAUSKOPF J, RAMAEKERS J G, et al. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders[J]. Progress in Neurobiology, 2020, 185:101732.
[6] American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5) [M].5th ed. Washington DC：American Psychiatric Publishing,2013.
[7] 司天梅, 杨建中, 舒良, 等．阳性和阴性症状量表(PANSS, 中文版) 的信、效度研究[J]. 中国心理卫生杂志, 2004, 18(1): 45-47. SI Tianmei, YANG Jianzhong, SHU Liang, et al. The reliability, validity of PANSS and its implication [J].Chinese Mental Health Journal, 2004,18(1):45-47.
[8] 邹义壮, 崔界峰, 王健, 等．精神分裂症认知功能成套测验中文版临床信度及效度的研究[J]. 中华精神科杂志, 2009, 42(1): 29-33.
ZOU Yizhuang, CUI Jiefeng, WANG Jian, et al.Clinical reliability and validity of the Chinese version of measurement and treatment research to improve cognition in schizophrenia consensus cognitive battery[J]. Chinese Journal of Psychiatry,2009,42(1):29-33．
[9] JENSEN A R, ROHWER W J. The stroop color-word test: a review[J]. Acta Psychologica, 1966, 25(1): 36-93.
[10] 谭梅娟, 李靖．精神分裂症患者梅毒感染的流行病学调查[J]. 现代检验医学杂志, 2018, 33(4): 125-126,130.
TAN Meijuan, LI Jing . Study on Syphilis infection among inpatients with schizophrenia [J]. Journal of Modern Laboratory Medicine, 2018,33(4):125-126,130.
[11] CAO Ting, ZHEN Xuechu. Dysregulation of miRNA and its potential therapeutic application in Schizophrenia[J]. CNS Neuroscience & Therapeutics,2018, 24(7): 586-597.
[12] KANNAN M, LEE S J, SCHWEDHELM-DOMEYER N, et al. p250GAP is a novel player in the Cdh1-APC/smurf1 pathway of axon growth regulation[J]. PLoS One, 2012, 7(11): e50735.
[13] MARLER K J, SUETTERLIN P, DOPPLAPUDI A, et al. BDNF promotes axon branching of retinal ganglion cells via miRNA-132 and p250GAP[J]. The Journal of Neuroscience, 2014, 34(3): 969-979.
[14] IMPEY S, DAVARE M, LESIAK A, et al. An activityinduced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling[J]. Molecular and Cellular Neurosciences, 2010, 43(1): 146-156.
[15] HANSEN K F, KARELINA Kate, SAKAMOTO K,et al. miRNA-132: a dynamic regulator of cognitive capacity[J]. Brain Structure & Function, 2013, 218(3):817-831.
[16] OHI K, HASHIMOTO R, NAKAZAWA T, et al. The p250GAP gene is associated with risk for schizophrenia and schizotypal personality traits[J]. PLoS One, 2012,7(4): e35696.
[17] CHUA C E L, TANG B L. MiR-34a in neurophysiology and neuropathology[J]. Journal of Molecular Neuroscience, 2019, 67(2): 235-246.
[18] JAUHARI A, SINGH T, SINGH P, et al. Regulation of miR-34 family in neuronal development[J]. Molecular Neurobiology, 2018, 55(2): 936-945.
[19] ORGANISTA-JU?REZ D, JIM?NEZ A, ROCHA L,et al. Differential expression of miR-34a, 451, 1260,1275 and 1298 in the neocortex of patients with mesial temporal lobe epilepsy [J]. Epilepsy Research, 2019,157: 106188.
[20] HU Kai, XIE Yuanyuan, ZHANG Chen, et al.MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus[J]. BMC Neuroscience, 2012, 13: 115.
[21] LIANG Tingying, LOU Jiyu. Increased expression of miR-34a-5p and clinical association in acute ischemic stroke patients and in a rat model[J]. Medical Science Monitor, 2016, 22: 2950-2955.
[22] GROSSI I, RADEGHIERI A, PAOLINI L, et al.MicroRNA-34a-5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study[J].International Journal of Molecular Medicine, 2021,47(2): 533-546.
[23] SARKAR S, ENGLER-CHIURAZZI E B,CAVENDISH J Z, et al. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer’s disease-like pathology[J]. Brain Research, 2019, 1721:146327.
[24] CHEN Peng, CHEN Fuchao, LEI Jiexin, et al.Activation of the miR-34a-mediated SIRT1/mTOR signaling pathway by urolithin a attenuates D-Galactose-induced brain aging in mice[J].Neurotherapeutics, 2019, 16(4): 1269-1282.

备注/Memo

备注/Memo:
基金项目：武汉市卫生计生委科研项目（WJ20195036），资助单位：武汉市卫生计生委。
作者简介：钱博文（1982-)，男，硕士，主治医师，研究方向: 精神卫生，E-mail：qbw43052156@163.com。
更新日期/Last Update: 2023-01-15